المؤلفون: Sung‐Min Kim, Naery Euphrasia Yang, Dajeong Jeong, Jiwon Yun, Sohee Ryu, Sung‐Soo Yoon, Yong‐Oon Ahn, Dong Soon Lee

المصدر: eJHaem, Vol 1, Iss 2, Pp 563-566 (2020)

مصطلحات موضوعية: MRD (minimal residual disease), Myeloma, NGF (next‐generation flow), Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2688-6146Test

الوصول الحر: https://doaj.org/article/ba25d9fdf7404a0d90e74ced08857d6aTest

المؤلفون: Qingqing Zheng, Chuang Jiang, Haiyan Liu, Wenge Hao, Pengfei Wang, Haiying Huang, Ziping Li, Jiabi Qian, Maoxiang Qian, Hui Zhang

المصدر: Frontiers in Oncology, Vol 10 (2020)

مصطلحات موضوعية: acute lymphoblast leukemia, risk stratification, relapse, FOXO1, MRD—minimal residual disease, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2020.629875/fullTest; https://doaj.org/toc/2234-943XTest

الوصول الحر: https://doaj.org/article/a7eb2aaf9a4443ca93f53712c085ea64Test

المؤلفون: Qingqing Zheng, Chuang Jiang, Haiyan Liu, Wenge Hao, Pengfei Wang, Haiying Huang, Ziping Li, Jiabi Qian, Maoxiang Qian, Hui Zhang

المصدر: Frontiers in Oncology, Vol 10 (2020)

مصطلحات موضوعية: acute lymphoblast leukemia, risk stratification, relapse, FOXO1, MRD—minimal residual disease, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2020.579673/fullTest; https://doaj.org/toc/2234-943XTest

الوصول الحر: https://doaj.org/article/abb26d84edc74ff587e87afdc41ec66aTest

المؤلفون: Zachary S, Bohannan, Frederick, Coffman, Antonina, Mitrofanova

المصدر: Computational and Structural Biotechnology Journal, Vol 20, Iss, Pp 583-597 (2022)
Computational and Structural Biotechnology Journal

مصطلحات موضوعية: COG, Children's Oncology Group, Bioinformatics, Random survival forest, ALL, Acute lymphblastic leukemia, Biophysics, Genomics, Clinical oncology, Biochemistry, Computer Science Applications, EFS, Event-free survival, Structural Biology, Machine learning, Genetics, B-ALL, B cell acute lymphoblastic leukemia, WBC, White blood cell count, TP248.13-248.65, ComputingMethodologies_COMPUTERGRAPHICS, Research Article, MRD, Minimal residual disease, Biotechnology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::773cc3f1c925f845295340a68d03e2fcTest
https://doi.org/10.1016/j.csbj.2022.01.003Test

المؤلفون: Chuang Jiang, Haiying Huang, Hui Zhang, Jiabi Qian, Pengfei Wang, Haiyan Liu, Wenge Hao, Ziping Li, Qingqing Zheng, Maoxiang Qian

المصدر: Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, endocrine system, Cyclophosphamide, FOXO1, acute lymphoblast leukemia, risk stratification, lcsh:RC254-282, Fusion gene, 03 medical and health sciences, 0302 clinical medicine, medicine, Original Research, relapse, MRD—minimal residual disease, business.industry, Cell cycle, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Pediatric cancer, Minimal residual disease, Leukemia, 030104 developmental biology, Real-time polymerase chain reaction, Oncology, 030220 oncology & carcinogenesis, Cancer research, business, hormones, hormone substitutes, and hormone antagonists, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ef3f81d03432b7f45ae07ee94689dfdTest
https://www.frontiersin.org/articles/10.3389/fonc.2020.579673/fullTest

المؤلفون: Qingqing Zheng (3067743), Chuang Jiang (6069884), Haiyan Liu (51889), Wenge Hao (9626150), Pengfei Wang (123133), Haiying Huang (1474156), Ziping Li (4760487), Jiabi Qian (6431336), Maoxiang Qian (4373875), Hui Zhang (7197)

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, acute lymphoblast leukemia, risk stratification, relapse, FOXO1, MRD—minimal residual disease

العلاقة: https://figshare.com/articles/dataset/Table_1_Down-Regulated_FOXO1_in_Refractory_Relapse_Childhood_B-Cell_Acute_Lymphoblastic_Leukemia_XLSX/13219640Test

الإتاحة: https://doi.org/10.3389/fonc.2020.579673.s002Test

المؤلفون: Qingqing Zheng (3067743), Chuang Jiang (6069884), Haiyan Liu (51889), Wenge Hao (9626150), Pengfei Wang (123133), Haiying Huang (1474156), Ziping Li (4760487), Jiabi Qian (6431336), Maoxiang Qian (4373875), Hui Zhang (7197)

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, acute lymphoblast leukemia, risk stratification, relapse, FOXO1, MRD—minimal residual disease

العلاقة: https://figshare.com/articles/dataset/Data_Sheet_1_Down-Regulated_FOXO1_in_Refractory_Relapse_Childhood_B-Cell_Acute_Lymphoblastic_Leukemia_pdf/13219637Test

الإتاحة: https://doi.org/10.3389/fonc.2020.579673.s001Test

المؤلفون: Tomalika Rahmat Ullah

المصدر: Journal of Bone Oncology
Journal of Bone Oncology, Vol 17, Iss, Pp-(2019)

مصطلحات موضوعية: 0301 basic medicine, HMGB1, High Mobility Group Box 1, lcsh:Diseases of the musculoskeletal system, HCC, Hepatocellular carcinoma, GPCRs, G protein-coupled chemokine receptors, MM, Multiple myeloma, MIF, Macrophage migration inhibitory factor, VEGF, Vascular endothelial growth factor, G-CSF, Granulocyte colony-stimulating factor, Review Article, AMC, Angiogenic monomuclear cells, CAM-DR, Cell adhesion‐mediated drug resistance, CXCR4, VHL, Von Hippel-Lindau, Chemokine receptor, 0302 clinical medicine, CL—CC, Chemokine ligand, CCX–CKR, Chemo Centryx–chemokine receptor, Medicine, EPI, Endogenous peptide inhibitor, CD4, Cluster of differentiation 4, PLC, Phospholipase C, Multiple myeloma, CTAP-III, Connective tissue-activating peptide-III, SFM-DR, Soluble factor mediated drug resistance, BM, Bone marrow, CXCR, CXC chemokine receptor, RANKL, Receptor activator of nuclear factor kappa-Β ligand, ERK, Extracellular signal related kinase, CNS, Central nervous system, EPC, Endothelial progenitor cells, PI3K, phosphoinositide-3 kinase, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, HSC, Hematopoietic stem cells, HPV, Human papillomavirus, EMD, Extramedullary disease, medicine.anatomical_structure, PKC, Protein kinase C, Oncology, 030220 oncology & carcinogenesis, EGF, Epidermal growth factor, JNK, Jun N-terminal kinase, HIV, Human Immunodeficiency Virus, MRD, Minimal residual disease, NHL, Non-Hodgkin's lymphoma, Cell signaling, HIF1α, Hypoxia-inducible factor-1 alpha, lcsh:RC254-282, WHIM, Warts, Hypogammaglobulinemia, Infections, and Myelokathexis, 03 medical and health sciences, CCR–CC, Chemokine receptor, Mediator, Pim, Proviral Integrations of Moloney virus, OCL, Octeoclast, IGF, Insulin-like growth factor, MMP, Matrix metalloproteinases, CSCs, Cancer stem cells, Tumor microenvironment, JAK/STAT, Janus Kinase signal transducer and activator of transcription, WM, Waldenström macroglobulinemia, business.industry, JAM-A, Junctional adhesion molecule-A, HD, Hodgkin's disease, HGF, Hepatocyte growth factor, medicine.disease, MAPK, Mitogen Activated Protein Kinase, CXCL, CXC chemokine ligand, OPG, Osteoprotegerin, 030104 developmental biology, RRMM, Relapsed/refractory multiple myeloma, Cancer research, PKA, protein kinase A, Bone marrow, lcsh:RC925-935, business, FGF, Fibroblast growth factor, Homing (hematopoietic), BMSC, Bone marrow stromal cells

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2aef32d7c524945afc1fdd274518216Test
http://europepmc.org/articles/PMC6658931Test

المؤلفون: Letizia Foroni, Jane F. Apperley, Mary Alikian, Robert Peter Gale

المصدر: Biomolecular Detection and Quantification, Vol 11, Iss C, Pp 4-20 (2017)
Biomolecular Detection and Quantification

مصطلحات موضوعية: Oncology, Pathology, SCT, stem cell transplant, Review Article, Disease, Biochemistry, lcsh:Microbiology, CMR, complete molecular response/remission, ZMW, zero-mode wave-guided, 0302 clinical medicine, LSC, leukemic stem cell, EURO-SKI, European Stop Tyrosine Kinase Inhibitor Study, DESTINY, De-Escalation and Stopping Treatment of Imatinib, Nilotinib or sprYcel in Chronic Myeloid Leukaemia, NTC, No Template Control, PCR, Polymerase Chain Reaction, lcsh:QH301-705.5, ABL, RT, reverse transcription, CP, chronic phase, ALL, acute lymphoblastic leukaemia, CAP, College of American Pathology, KDa, Kilo Dalton, AP, accelerated phase, μg, microgram, RT-dPCR, reverse transcription-digital polymerase chain reaction, 030220 oncology & carcinogenesis, NGS, TKD, tyrosine kinase domain, ARQ, armored RNA Quant, IRIS, interferon and cytarabine versus STI571, medicine.medical_specialty, Cancer therapy, IS, International Scale, cDNA, coding or complimentary DNA, RT-qPCR, reverse transcription-quantitative polymerase chain reaction, Chronic myeloid leukaemia, 03 medical and health sciences, ELN, European Leukaemia Net, STIM, stop imatinib, Molecular Biology, CML, chronic myeloid leukaemia, LPC, leukemic progenitor cells, NGS, next generation sequencing, BMT, bone marrow transplantation, Q-PCR, quantitative polymerase chain reaction, respiratory tract diseases, IC, inhibotory concentration, MMR, major molecular response/remission, SMRT, single-molecule real-time sequencing, Mbp, mega base pair, dPCR, digital polymerase chain reaction, m-bcr, minor-breakpoint cluster region, dMIQE, Minimum Information for Publication of Quantitative Digital PCR Experiments, PFS, Progression Free Survival, lcsh:QR1-502, GUSB, glucuronidase beta gene, Kbp, Kilo Base Pairs, μ-bcr, micro-breakpoint cluster region, ABL1, Abelson murine leukaemia virus, MRD, minimal residual disease, TKI, tyrosine kinase inhibitor, DNA, deoxyribonucleic acid, Structural Biology, hemic and lymphatic diseases, CES, capillary electrophoresis sequencing, CML, μl, microliter, breakpoint cluster region, Myeloid leukemia, allo-SCT, Allogeneic Stem Cell Transplantation, LoQ, limit of quantification, mRNA, messenger RNA, medicine.anatomical_structure, MRD, emPCR, emulsion PCR, Molecular Medicine, Ph, Philadelpia, WHO, World Health Organisation, ATP, adenosine triphosphate, Bp, base pair, NCCN, National Comprehensive Cancer Network, QC, Quality Control, BC, blast crisis, LoD, limit of detection, PB, Peripheral Blood, gDNA, genomic deoxyribonucleic acid, Internal medicine, InDels, insertions and deletions, Molecular monitoring, medicine, EAC, Europe Against Cancer, nM, manomolar, business.industry, dPCR, MR, deep molecular response/remission, M-bcr, major-breakpoint cluster region, Gold standard (test), lcsh:Biology (General), NEQAS, National External Quality Assessement Service, BM, bone marrow, BCR, breakpoint cluster region, Bone marrow, business, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38bbd66daeb393841cac660a98150a1aTest

المؤلفون: Anna Hockaday, David Allsup, Dena R. Howard, David Phillips, Laura Collett, Talha Munir, Andy C. Rawstron, Peter Hillmen, Jamie B. Oughton, Adrian Bloor

المصدر: Howard, D R, Munir, T, Hockaday, A, Rawstron, A C, Collett, L, Oughton, J B, Allsup, D, Bloor, A, Phillips, D & Hillmen, P 2016, ' Chemotherapy plus Ofatumumab at Standard or Mega dose in relapsed CLL (COSMIC) trial : Study protocol for a phase II randomised controlled trial ', Trials, vol. 17, no. 1, 456 . https://doi.org/10.1186/s13063-016-1581-0Test
Trials
Howard, DR, Munir, T, Hockaday, A, Rawstron, AC, Collett, L, Oughton, JB, Allsup, D, Bloor, A, Phillips, D & Hillmen, P 2016, ' Chemotherapy plus Ofatumumab at Standard or Mega dose in relapsed CLL (COSMIC) trial: study protocol for a phase II randomised controlled trial. ', Trials, vol. 17, 456 (2016) . https://doi.org/10.1186/s13063-016-1581-0Test

مصطلحات موضوعية: Oncology, Neoplasm, Residual, Time Factors, medicine.medical_treatment, Relapsed population, Medicine (miscellaneous), Dose selection, Randomised clinical trial, law.invention, chemistry.chemical_compound, Study Protocol, 0302 clinical medicine, Antineoplastic Agents, Immunological, Randomized controlled trial, Clinical Protocols, law, Recurrence, Antineoplastic Combined Chemotherapy Protocols, Bendamustine Hydrochloride, Pharmacology (medical), Drug Dosage Calculations, education.field_of_study, CLL, Chronic lymphocytic leukaemia, Antibodies, Monoclonal, Fludarabine, Treatment Outcome, Research Design, 030220 oncology & carcinogenesis, Bendamustine, Rituximab, Vidarabine, medicine.drug, MRD, Minimal residual disease, medicine.medical_specialty, FC, Population, Ofatumumab, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, Internal medicine, medicine, Humans, education, Cyclophosphamide, Chemotherapy, business.industry, Minimal residual disease, Leukemia, Lymphocytic, Chronic, B-Cell, United Kingdom, chemistry, Immunology, Phase II trial, business, 030215 immunology

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71ca3351838a3b9a019980827c2111ccTest
https://doi.org/10.1186/s13063-016-1581-0Test